Diabetic Ketoacidosis in Coronavirus Disease Patients With Type 2 Diabetes Mellitus
| Autor: | May Hnin Pwint Soe, Zin Thawdar Oo, May M Aung, Soe P Winn, Nyein Nyein Htun |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Pediatrics
medicine.medical_specialty Diabetic ketoacidosis endocrine system diseases Infectious Disease Disease Type 2 diabetes 030204 cardiovascular system & hematology medicine.disease_cause 03 medical and health sciences 0302 clinical medicine diabetic ketoacidosis Diabetes mellitus medicine Internal Medicine Coronavirus diabetes type 2 business.industry corona virus disease 2019 (covid-19) General Engineering Endocrinology/Diabetes/Metabolism Type 2 Diabetes Mellitus nutritional and metabolic diseases medicine.disease Pneumonia Respiratory failure covid-19 diabetes mellitus business 030217 neurology & neurosurgery |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| Popis: | The occurrence of diabetes is increasing globally and carries a variety of complications, such as thromboembolism, acute cerebrovascular accidents, and diabetic ketoacidosis (DKA). Although DKA is not commonly associated with type 2 diabetes (T2D), it can manifest in patients who have underlying comorbidities predisposed to DKA. Since the emergence of the coronavirus disease (COVID-19) pandemic, we have seen many cases and studies on the underlying pathophysiology of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia with or without respiratory failure. We have also learned that the angiotensin-converting enzyme receptor is one of the major entry sites of SARS-CoV-2 infection, and it might be one of the causes that predispose patients to DKA. However, few studies exist that explore the development of DKA in T2D with SARS-CoV-2 infection. We present two cases of patients with DKA and COVID-19 treated with an insulin regimen with no further complications. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|